+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical Features of Refractory Pouchitis with Penetrating Lesions and the Efficacy of Infliximab Treatment for Patients with Ulcerative Colitis after Restorative Proctocolectomy



Clinical Features of Refractory Pouchitis with Penetrating Lesions and the Efficacy of Infliximab Treatment for Patients with Ulcerative Colitis after Restorative Proctocolectomy



Digestion 92(3): 147-155



Chronic pouchitis with penetrating anal lesions often leads to pouch failure after restorative proctocolectomy. The aim of this study was to analyze those predictors and to evaluate the effects of infliximab (IFX). We reviewed patients’ backgrounds and performed a prospective trial of IFX treatment. Possible pre-operative factors were analyzed. Efficacy was assessed by comparing the pouchitis disease activity index (PDAI) and peri-anal DAI. Long-term efficacy was assessed via the rate of pouch failure. A total of 41 patients with refractory pouchitis were included. Although the patients with penetrating lesions were younger than those without, neither predictive pre-operative factors nor a correlation of C-related protein levels were observed. A total of 10 patients with penetrating lesions were enrolled for IFX treatment. Although the PDAI and peri-anal DAI decreased significantly (p = 0.04 and p = 0.02, respectively), the primary non-responders during the induction of IFX were 3 patients with obvious abscesses. The 1-year cumulative pouch failure rate was 0% in patients without abscesses and 50% in patients with abscesses under IFX maintenance. IFX treatment for refractory pouchitis with penetrating complications appears to be effective. However, once penetrating lesions develop to abscesses, these lesions are difficult to heal.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057415612

Download citation: RISBibTeXText

PMID: 26343749

DOI: 10.1159/000438922


Related references

Successful treatment with tacrolimus of refractory pyoderma gangrenosum with pouchitis after restorative proctocolectomy for ulcerative colitis. Immunological Medicine 41(3): 142-146, 2018

Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut 38(3): 362-364, 1996

Pouchitis may increase the risk of dysplasia after restorative proctocolectomy in patients with ulcerative colitis. Colorectal Disease 14(1): 92-97, 2012

Risk of cancer in patients with chronic pouchitis after restorative proctocolectomy for ulcerative colitis. Colorectal Disease 13(1): 58-66, 2011

Heterogeneity of pouchitis after restorative proctocolectomy for ulcerative colitis. Gastroenterology 106(4 Suppl. ): A790, 1994

Anatomic extent of colitis and disease severity are not predictors of pouchitis after restorative proctocolectomy for mucosal ulcerative colitis. Techniques in Coloproctology 10(1): 29-34; Discussion 34-6, 2006

Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study. Therapeutic Advances in Gastroenterology 10(2): 199-206, 2017

Pouchitis-associated pyoderma gangrenosum following restorative proctocolectomy for ulcerative colitis. European Journal of Gastroenterology and Hepatology 16(10): 1057-1058, 2004

Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. Journal of the Royal College of Surgeons of Edinburgh 46(6): 334-337, 2001

Elemental diet therapy for pouchitis following restorative proctocolectomy for ulcerative colitis. Journal of Crohn's and Colitis 7(4): E155, 2013

Predictors for acute and chronic pouchitis following restorative proctocolectomy for ulcerative colitis. Colorectal Disease 10(8): 805-813, 2008

Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis. World Journal of Gastroenterology 20(29): 9665-9674, 2014

Frequency, Clinical Features and Factors Associated with Pouchitis after Proctocolectomy with Ileo-Pouch-Anal Anastomosis in Patients with Ulcerative Colitis: A Latin-American Country Retrospective-Cohort Study. Digestive Surgery 32(6): 489-495, 2016

Mucosa-Associated Microbiota and Risk of Chronic and/or Relapsing Pouchitis After Restorative Proctocolectomy for Ulcerative Colitis. Gastroenterology 138(5): S-865-S-866, 2010

Pouchitis and pre-pouch ileitis developed after restorative proctocolectomy for ulcerative colitis: a case report. World Journal of Gastroenterology 13(4): 643-646, 2007